IL151493A0 - Use of dermaciclane for the treatment of anxiety and depression - Google Patents

Use of dermaciclane for the treatment of anxiety and depression

Info

Publication number
IL151493A0
IL151493A0 IL15149301A IL15149301A IL151493A0 IL 151493 A0 IL151493 A0 IL 151493A0 IL 15149301 A IL15149301 A IL 15149301A IL 15149301 A IL15149301 A IL 15149301A IL 151493 A0 IL151493 A0 IL 151493A0
Authority
IL
Israel
Prior art keywords
dermaciclane
anxiety
depression
treatment
Prior art date
Application number
IL15149301A
Other languages
English (en)
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of IL151493A0 publication Critical patent/IL151493A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15149301A 2000-03-17 2001-03-16 Use of dermaciclane for the treatment of anxiety and depression IL151493A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00302207A EP1133986A1 (en) 2000-03-17 2000-03-17 Use of deramciclane for the treatment of anxiety and depression
PCT/FI2001/000266 WO2001068067A2 (en) 2000-03-17 2001-03-16 Use of deramciclane for the treatment of anxiety and depression

Publications (1)

Publication Number Publication Date
IL151493A0 true IL151493A0 (en) 2003-04-10

Family

ID=8172804

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15149301A IL151493A0 (en) 2000-03-17 2001-03-16 Use of dermaciclane for the treatment of anxiety and depression

Country Status (19)

Country Link
EP (2) EP1133986A1 (cs)
JP (1) JP2004500394A (cs)
KR (1) KR20020089399A (cs)
CN (1) CN1418094A (cs)
AR (1) AR028260A1 (cs)
AU (2) AU4838301A (cs)
BG (1) BG107196A (cs)
BR (1) BR0109172A (cs)
CA (1) CA2403350A1 (cs)
CZ (1) CZ20023025A3 (cs)
EA (1) EA200200987A1 (cs)
HU (1) HUP0204528A3 (cs)
IL (1) IL151493A0 (cs)
MX (1) MXPA02008998A (cs)
NO (1) NO20024331L (cs)
PL (1) PL359288A1 (cs)
SK (1) SK12982002A3 (cs)
WO (1) WO2001068067A2 (cs)
ZA (1) ZA200207111B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20002612A0 (fi) * 2000-11-28 2000-11-28 Orion Yhtymae Oyj Yhdistelmäterapia serotoniinivälityksen häiriöiden hoitamiseksi
CN105456257A (zh) * 2014-09-25 2016-04-06 中国人民解放军军事医学科学院毒物药物研究所 胺类化合物的光学异构体治疗焦虑障碍的医药用途
CN109758452A (zh) * 2014-09-25 2019-05-17 石药集团中奇制药技术（石家庄）有限公司 胺类化合物治疗疼痛的医药用途
CN105497021A (zh) * 2014-09-25 2016-04-20 中国人民解放军军事医学科学院毒物药物研究所 胺类化合物治疗焦虑障碍的医药用途
CN105497020A (zh) * 2014-09-25 2016-04-20 中国人民解放军军事医学科学院毒物药物研究所 胺类化合物的光学异构体治疗疼痛的医药用途

Also Published As

Publication number Publication date
AU2001248383A1 (en) 2002-07-16
AR028260A1 (es) 2003-04-30
PL359288A1 (en) 2004-08-23
AU4838301A (en) 2001-09-24
WO2001068067A2 (en) 2001-09-20
JP2004500394A (ja) 2004-01-08
CZ20023025A3 (cs) 2003-05-14
EA200200987A1 (ru) 2003-04-24
HUP0204528A2 (en) 2003-05-28
HUP0204528A3 (en) 2004-08-30
NO20024331D0 (no) 2002-09-10
EP1263424A2 (en) 2002-12-11
KR20020089399A (ko) 2002-11-29
MXPA02008998A (es) 2003-04-25
NO20024331L (no) 2002-09-10
EP1133986A1 (en) 2001-09-19
CA2403350A1 (en) 2001-09-20
BR0109172A (pt) 2002-11-26
ZA200207111B (en) 2003-12-04
WO2001068067A3 (en) 2002-07-11
CN1418094A (zh) 2003-05-14
BG107196A (bg) 2003-02-28
SK12982002A3 (sk) 2003-05-02

Similar Documents

Publication Publication Date Title
AU3947902A (en) Therapeutic agents and methods of use thereof for the modulation of angiogenesis
EP1423120A4 (en) 2H-PHTALAZINE-1-ONES AND METHODS OF USE THEREOF
GB0109537D0 (en) Well treatment fluids and methods for the use thereof
IL157577A0 (en) Disposable underpants and method of providing the same
EP1283702A4 (en) MEDICAL ASSOCIATION ARRANGEMENT AND METHOD OF THE APPLICATION
AU7593001A (en) Alpha-msh related compounds and methods of use
EP1392292A4 (en) PYRANOINDAZOLES AND THEIR USE IN GLAUCOMA TREATMENT
GB0322131D0 (en) Absorbent garment and method of providing the same
AU1334602A (en) Osteopontin-coated surfaces and methods of use
AU8235601A (en) Dispenser and method of use
GB0019302D0 (en) Biological materials and the use thereof for the treatment of disease
IL150289A0 (en) Drug combination for the treatment of depression and related disorders comprising mirtazapine
AU2002363938A8 (en) Methods and use of motoneuronotropic factors
IL155874A0 (en) Treatment of anxiety disorders
GB0011052D0 (en) Medical device and use thereof
AU2002337843A8 (en) Processes for the preparation of substituted isoxazoles and 2-isoxazolines
GB0119025D0 (en) Compounds and their therapeutic use
IL151493A0 (en) Use of dermaciclane for the treatment of anxiety and depression
AU5565401A (en) Materials and methods for the treatment of depression
GB0007217D0 (en) Materials and methods relating to the treatment of leukaemias
IL149705A0 (en) Combination treatment for depression and anxiety
AU2003259689A1 (en) 3-imino-2-indolones for the treatment of depression and/or anxiety
EP1367123A4 (en) NEUROTONIN AND ITS USE
GB0106316D0 (en) Apparatus for use in the treatment of hair
EP1392460A4 (en) AMINOSILANOL HYDROFLUORIDES AND THEIR USE